Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2006 Mar;21(1):142–146. doi: 10.1007/BF02913083

Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity

Meena Verma 1,✉, Sangeeta Paneri 1, Preetha Badi 1, P G Raman 2
PMCID: PMC3453763  PMID: 23105586

Abstract

Non-insulin dependent diabetes mellitus (NIDDM) is the most rapidly growing chronic metabolic disorder in the world. With advancement in the age and duration of diabetes there is a gradual tendency for the level of blood sugar to rise along with a subsequent increase in the HbA1c as well as in the fasting insulin level. Whether this is an aging process or increased frequency of diabetes is still controversial. The correlation between glucose and insulin sensitivity is consistent with the idea that the degree of chronic hyperglycemia is a cause of excessive insulin resistance in type 2 diabetes, i.e. the insulin resistance which characterizes type 2 diabetes but not nondiabetic subjects matched for age, gender, family history and duration of diabetes. The study comprised a total of 76 subjects out of which 30 were normal, non-diabetic persons and the rest 46 were diabetics with different duration of time in years, after being diagnosed diabetic. Data was analyzed after dividing the subjects into four groups—Group 1 comprised of one year old diabetics, Group 2 was made up of those, who had diabetes, for the past 2–5 years, Group 3 included patients who were diabetic since more than 5 years and Group 4 included non-diabetics as the normal control group. The results obtained indicated that the HbA1c levels showed a significant increase with the duration of diabetes as well as the insulin level showed a significant correlation after adjustment for age, sex and duration of diabetes.

Key words: Glycation, HbA1c, Insulin Resistance, Fasting Blood Glucose, Post Prandial Blood Glucose

Full Text

The Full Text of this article is available as a PDF (60.9 KB).

References

  • 1.The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. (1995); 44: 968–983. [PubMed]
  • 2.Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes, (UKPDS 35) prospective observational study. BMJ. 2002;321:405–412. doi: 10.1136/bmj.321.7258.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Burm H.F., Haney D.N., Grabbay K.H., et al. Further identification of the nature and the linkage of the carbohydrates in hemoglobin. Alc Biochem. Biophys. Res. Comm. 1975;67:103–109. doi: 10.1016/0006-291X(75)90289-2. [DOI] [PubMed] [Google Scholar]
  • 4.Rahbar S. An abnormal hemoglobin in red cells of diabetics. Clin. Chim. Acta. 1968;22:296–298. doi: 10.1016/0009-8981(68)90372-0. [DOI] [PubMed] [Google Scholar]
  • 5.Trivelli L.A., Ranney H.M., Lai H-T. Hemoglobin components in patients with diabetes mellitus. N. Engl. J. Med. 1971;284:353–357. doi: 10.1056/NEJM197102182840703. [DOI] [PubMed] [Google Scholar]
  • 6.Arnetz B.B., Kallner A., Theorell T. The influence of aging on HbA1c. J. Gerontol. 1982;37:648–650. doi: 10.1093/geronj/37.6.648. [DOI] [PubMed] [Google Scholar]
  • 7.Kilpatrick E.S., Dominiczak M.H., Small M. The effects of aging on glycation and the interpretation of glycemic control in type 2 diabetes. Q.J. Med. 1996;89:307–312. doi: 10.1093/qjmed/89.4.307. [DOI] [PubMed] [Google Scholar]
  • 8.Kabadi U.M. Glycosylation of proteins. Lack of influence on aging. Diabetes Care. 1998;11:421–432. doi: 10.2337/diacare.11.5.429. [DOI] [PubMed] [Google Scholar]
  • 9.Defronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM: A balanced overview. Diabetes Care. 1992;15(3):318–368. doi: 10.2337/diacare.15.3.318. [DOI] [PubMed] [Google Scholar]
  • 10.Mykkanen L., Zaccaro D.J., Hales C.N., Festa A., Haffner S.M. The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type 2 diabetes: The Insulin Resistance Atherosclerosis Study. Diabetologia. 1999;42(9):1060–1066. doi: 10.1007/s001250051271. [DOI] [PubMed] [Google Scholar]
  • 11.The expert committee on the diagnosis and classification of diabetes mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;10:1183–1197. doi: 10.2337/diacare.20.7.1183. [DOI] [PubMed] [Google Scholar]
  • 12.David M., Nathan M.D. Initial management of glycemia in type 2 diabetes mellitus. NEJM. 2002;347(17):1342–1349. doi: 10.1056/NEJMcp021106. [DOI] [PubMed] [Google Scholar]
  • 13.Rao G.M., Morghom L.O., Abukhris A.A., Mansori S.S., Alphgih F.A., Ragale L.Y. HbA1c and blood glucose levels in Libyan diabetic patients. Trop. Geogr. Med. 1986;38(4):391–397. [PubMed] [Google Scholar]
  • 14.Shera A.S., Jawad F., Maqsood A., Jamal S., Azfar M., Ahmed U. Prevalence of chronic complications and associated factors in type 2 diabetes. J. Pak. Med. Assoc. 2004;54(2):54–59. [PubMed] [Google Scholar]
  • 15.Sampson M.J., Hughes D.A., Carrier M.J., Davies I.R. Status of HbA1c during acute hyperglycemia in type 2 diabetes. Diabetes care. 2002;25:537–541. doi: 10.2337/diacare.25.3.537. [DOI] [PubMed] [Google Scholar]
  • 16.Rosetti L., Giaccari A., Defronzo R. Glucose toxicity. Diabetes care. 1990;13:610–630. doi: 10.2337/diacare.13.6.610. [DOI] [PubMed] [Google Scholar]
  • 17.Yki-Jarvinen H. Glucose toxicity. Endocr Rev. 1992;13:415–431. doi: 10.1210/er.13.3.415. [DOI] [PubMed] [Google Scholar]
  • 18.Mandarino L., Baker B., Rizza R., Genest J., Gerich J. Infusion of insulin repairs human adipocyte, glucose metabolism in vitro without decreasing adipocyte insulin receptor binding. Diabetologia. 1984;27:358–363. doi: 10.1007/BF00304850. [DOI] [PubMed] [Google Scholar]
  • 19.Mathews D., Hosker J., Naylor B. Insulin resistance and beta-cell functioning from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–419. doi: 10.1007/BF00280883. [DOI] [PubMed] [Google Scholar]
  • 20.Reaven G. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 1995;75:473–486. doi: 10.1152/physrev.1995.75.3.473. [DOI] [PubMed] [Google Scholar]
  • 21.Meneilly G.S., Tessier D. Diabetes in the elderly. Diabet. Med. 1995;12:949–960. doi: 10.1111/j.1464-5491.1995.tb00405.x. [DOI] [PubMed] [Google Scholar]
  • 22.Evans J.L., Goldfine I.D. Glucose Status in Postmenopausal women. Endocr. Rev. 2002;23:599–622. doi: 10.1210/er.2001-0039. [DOI] [PubMed] [Google Scholar]
  • 23.Mayumi O., Seiji N., Yoko I., Eiko Y., et al. Effects of Post-menopausal Hormone Replacement Therapy on HbA1c levels. Diabetes care. 2003;26:1088–1092. doi: 10.2337/diacare.26.4.1088. [DOI] [PubMed] [Google Scholar]
  • 24.Clark C.M., Vinicor F. Introduction: Risks of benefits of intensive management in NIDDM. The Fifth Regenstrief. Conference. Ann. Intern. Med. 1996;124:81–85. [PubMed] [Google Scholar]
  • 25.Colwell J.A. The feasibility of intensive insulin management in NIDDM: Implications of the Veterans Affairs Cooperative Study on Glycemic Control and complications in NIDDM. Ann. Intern. Med. 1996;124:131–135. doi: 10.7326/0003-4819-124-1_part_2-199601011-00010. [DOI] [PubMed] [Google Scholar]
  • 26.Kitabchi A.E., Bryer Ash M. NIDDM: New aspects of management. Hosp. Pract. 1997;32:135–164. doi: 10.1080/21548331.1997.11443446. [DOI] [PubMed] [Google Scholar]
  • 27.Gloria-Botthini F., Antonacci E., Bottini N., Ogana A., Borgiani P., Santis G., Lucarini N. Rh blood groups and diabetic disorders: Is there an effect on glycosylated hemoglobin level? Hum. Biol. 2000;72(2):287–294. [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES